A Clinical Update on Chronic Lymphocytic Leukemia. II. Critical Analysis of Current Chemotherapeutic Modalities

This publication has 22 references indexed in Scilit:

• VAD chemotherapy—toxicity and efficacy—in patients with multiple myeloma and other lymphoid malignancies
  Hematological Oncology, 2006
• Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial.
  Journal of Clinical Oncology, 1991
• Correction of neutropenia associated with chronic lymphocytic leukaemia following treatment with granulocyte-macrophage colony-stimulating factor
  Annals of Hematology, 1991
• 2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside
  Leukemia & Lymphoma, 1991
• Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate
  The American Journal of Medicine, 1990
• Pentostatin in Refractory Chronic Lymphocytic Leukemia: A Phase II Trial of the European Organization for Research and Treatment of Cancer
  JNCI Journal of the National Cancer Institute, 1990
• Long‐term results of the CHOP regimen in stage C chronic lymphocytic leukaemia
  British Journal of Haematology, 1989
• Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival
  British Journal of Haematology, 1989
• Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group
  American Journal of Hematology, 1988
• Pulmonary toxicity associated with fludarabine monophosphate
  Investigational New Drugs, 1987